Clinical trial
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the…
NCT00064025 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00064025 |
|---|---|
| Title | Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus |
| Official title | A Phase II Pilot Investigation Of The Relationship Of Short Term Depo-Provera (Medroxyprogesterone Acetate) Exposure To The Morphologic , Biochemical, And Molecular Changes In Primary Endometroid Adenocarcinoma of the Uterine Corpus |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | Laboratory Biomarker Analysis, Medroxyprogesterone, Therapeutic Conventional Surgery |
| Enrollment | 75 |
| Start date | Apr 1, 2004 |
| Primary completion | Sep 1, 2010 |
| First posted | Jul 9, 2003 |
| Last update posted | Apr 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: